This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a 'bench to bedside' approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.
This 13 week core course aims to:
One week of practical training is provided at the start of the course. This course is assessed through a lab notebook, group assessment, critical essay and an exam that focuses on data analysis and interpretation.
In the second semester, you can choose from a range of 3 week optional courses, before taking the core course “Designing a Research Project”.
In this 14 week core course you will:
Note: students must have a minimum of grade C in semesters 1 and 2 in order to proceed to the research project.
The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies, those wishing to work in the health services sector, and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
The MSc in Cancer Medicine will provide students with new knowledge of how precision medicine can improve and shape future healthcare. Students will gain hands-on experience of molecular techniques and the equipment/devices used in a modern molecular laboratory; the course will provide training in laboratory and research skills that are applicable across multiple scientific disciplines in a supportive learning environment. Students will be able to evaluate how novel therapeutic approaches can be used to stratify patients into treatment groups for better clinical management (stratified / precision medicine). They will observe the delivery of precision medicine through tours of the Northern Ireland Cancer Centre.
There are optional modules in the second semester allowing students to explore.the fundamental principles of Carcinogenesis and the translational approaches (including cutting edge technologies) which allow cancer scientists and clinicians to advance our understanding and treatment of cancers. The Precision Cancer Medicine stream provides a comprehensive overview of the current understanding of the Hallmarks of Cancer from the role of genetic/epigenetic alterations, cell cycle control and metastases/angiogenesis to the development of applications to help diagnose cancers earlier, improve treatments, rationally design clinical trials and reduce chemotherapy drug resistance.
The Radiation Oncology stream will develop skills in understanding the biological principles of radiotherapy and its clinical applications in the treatment of cancer. This will include the physical and chemical basis of radiation interactions and the biological consequences of radiation exposures. Clinical aspects of Radiation Oncology will be covered including principle of advanced radiotherapy delivery, cancer imaging techniques and biomarker discovery.
Importantly, both streams show how our improved understanding of the molecular processes driving cancer growth and spread can be ‘translated’ through research-intensive MSc projects to improve the treatment and survival of cancer patients.
The strong links between us and the biotech and biopharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
WORLD CLASS FACILITIES
INTERNATIONALLY RENOWNED EXPERTS
Research Translational: from Concept to Commercialisation (Full Year)
Diagnosis and Treatment (Semester 1)
Cancer Biology (Semester 1)
Students will make a selection from the following modules:
Building on the biological basis of radiotherapy, this module will develop knowledge and skills in understanding clinical radiotherapy and medical imaging. Through the delivery of a multidisciplinary taught programme, students will cover clinical tumour and normal tissue biology, radiological imaging and the design of radiotherapy treatment plans. This will develop the clinical rationale for radiotherapy in the treatment of cancer and highlight emerging treatment combinations and techniques for biomarker discovery in radiation oncology.Biology and Imaging
You will undertake a project in the Centre for Cancer Research and Cell Biology.
This module comprises the write-up contribution to the overall research element of the programme, with the Research Project (SCM 8067). The Dissertation will represent the student’s personal studies in the literature, a description of their experimental execution of their project, data presentation, analysis and interpretation, followed by critical discussion and conclusions.
The School is equipped with a range of state-of-the-art equipment, which would help provide relevant practical experience for the students. Therefore the course aims to help students develop the necessary knowledge and practical skills to work in various areas within the pharmaceutical industry, including formulation, regulatory, and analytical services. Students will have a holistic view on the drug development process and be able to solve common pharmaceutical problems by critically evaluating and discussing the scientific literature.
The course is offered on a one year full-time basis, taught over three terms. It includes six taught modules in the first two terms in which all lecture material will be provided on our VLE to enable access.
If you wish to study MRes Cancer biology and Therapy, you must initially apply for MSc Cancer Biology and Therapy and successfully complete the first semester modules.
GSK, Quay Pharma, Rosemont Pharmaceuticals Ltd. and MHRA etc.
The MSc programme is delivered not only via the conventional means of face-to-face lectures, workshops, tutorials and seminars, but the use of online technologies such as videos and discussion forum would also help integrate students’ learning into their normal daily activities.
Practical classes, problem-based-learning exercises related to industrial challenges and reflective activities throughout the course would also help develop students’ ability to solve pharmaceutical problems practically and provide students an opportunity to apply their knowledge into practice, particularly in relation to the need for appropriate formulation design and development, and how these factors affect clinical outcomes in practice.
A variety of assessment methods will be used for this MSc course, including essays, oral presentations, posters, written examinations and laboratory reports.
Students on the course have opportunities to visit our industrial collaborators who specialise in liquid and solid dosage forms, which aim to provide an insight to students about the pharmaceutical industry and the various roles available in industry. Guest lectures and workshops provided at UCLan from the pharmaceutical industry and regulatory bodies also supplement the various modules studied in the course.
Graduate careers include: formulation scientist, PhD research student, and quality control technician.
Graduates may apply for further PhD study at UCLan or other institutions following completion of the MSc Programme. Alternatively, graduates aim to find jobs in the pharmaceutical industry as a formulation scientist, regulatory affairs officer and other roles in industry.
Eligible students may also be able to conduct their MSc research project in collaboration with an industrial partner in semester 3 as part of their MSc studies. This could be in the UK or overseas, subject to availability and agreement with the industrial organisation.
The specifically designed Pharmaceutical Sciences laboratories have excellent facilities to carry out teaching and research in pharmaceutical sciences. For example, a single-punch tablet press and powder encapsulation equipment help provide practical experience of small scale solid dosage form manufacturing. Other specialist equipment such as coating and spray drying instrument also help enhance students’ learning experience at the University. The characterisation of various dosage forms in accordance to the BP or USP methods can also be carried out using dissolution, disintegration, friability testers etc.
Various advanced drug delivery devices for pulmonary, oral and transdermal applications are also available for both teaching and research at the School. Students would also be able to use the superb analytical instrument available at the University for their practical classes and research project.
Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation.
With around 40% of all cancer cure cases involving radiotherapy and the UK soon to have a proton therapy service, the need for multidisciplinary scientists in this field has never been greater.
We aim to develop multidisciplinary scientists to create the necessary skill base that will drive radiotherapy forward in the UK.
This course will enable you to train as a multidisciplinary scientist in this area by covering a variety of subjects in content that is delivered by staff with a range of expertise, including physicists, biologists, engineers, clinicians and oncologists.
Our collaboration with The Christie will allow you to undertake unique research projects in its radiotherapy facilities that cannot be carried out anywhere else in the UK or most of Europe.
This course aims to help you develop:
You will be taught by academics from the University and clinical scientists at The Christie, meaning both fundamental science and its clinical application will be covered equally.
Units are delivered in one-week blocks with a mix of face-to-face content delivery and hands-on practical sessions.
There will be a number of assessed and non-assessed activities to develop your key skills and expand your knowledge base.
There is an also online pre-course element, which will be the beginning of your multidisciplinary scientific journey.
After the taught units, there is an supervised research project that will put into practice the key skills and knowledge acquired in the taught component.
The taught units will be assessed through multiple choice exams and practical assessments.
The research project will be assessed through the submission of a short report and oral presentation.
The taught component, which includes the five core and three optional units, will amount to 120 credits of the 180 credits required for an MSc qualification.
The remaining 60 credits will be obtained through a supervised research project.
Much of the course content is delivered through a collaboration with The Christie .
Our collaboration with The Christie means you will have access to an MRI image guided radiotherapy linear accelerator and a proton therapy centre incorporating a dedicated research room for your research project.
You will also be able to access a range of library and IT facilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service .
Individual taught units from this MSc can be offered to industry and healthcare professionals as part of a career and professional development programme. Please contact us for further information.
This course will help you gain the knowledge and skills to become a leading healthcare scientist in the public or private sector.
It may also be of interest if you are a healthcare worker in the field of radiotherapy who wishes to advance your career.
The master's qualification gained could act as a stepping stone to further academic qualifications or careers involving medical science research.
Improved global life expectancy has resulted in a cancer epidemic. It is well recognised that accurate early diagnosis is an essential aspect of the administration of increasingly expensive and tailored cancer treatment care plans.
The Biomedical Sciences (Cancer Biology) MSc programme has been devised to provide knowledge of key aspects of this increasingly important disease area.
You will become familiar with the genetic and cellular changes occurring in both solid and blood-borne cancers, the current and emerging technological approaches for diagnosis of the disease and the effect on pertinent cellular changes on patient prognosis. Studies on populations and the influence of genotypic variation will ensure that you are qualified to make sense of cancer statistics.
You are able to tailor your programme by selecting from a menu of option modules and pursuing a research project in an area ranging from molecular through to cellular or tissue-based aspects of cancer.
During the course you will join our thriving research environment and will have access to excellent laboratory facilities within the Faculty. On successful completion of the course you will be equipped to take forward your career with an in-depth knowledge of this increasingly common disease area.
The course is accredited by the Institute of Biomedical Science (IBMS).
The Cancer Biology MSc equips students for careers in the research sector, for example in academia or in the biotechnology or pharmaceutical industries.
Depending on the options that are taken by the student, in addition to their in-depth knowledge of molecular and cellular changes that occur in cancer, the student may also gain a detailed knowledge of the –OMICs topics alongside immunodiagnostics and immunotherapeutics. These areas of study open up the choices that students may select in terms of careers.
Our alumni have gone on to study PhDs or have gone on to work in the biotechnology industries in drug discovery roles.
Do you have a clear and specific interest in cancer, stem cells or developmental biology? Join our programme and combine research in oncology, molecular developmental biology and genetics. Discover the mysteries of embryonic growth, stem cells, signalling, gene regulation, evolution, and development as they relate to health and disease.
Given that fundamental developmental processes are so often impacted by disease, an understanding of these processes is vital to the better understanding of disease treatment and prevention. Adult physiology is regulated by developmental genes and mechanisms which, if deregulated, may result in pathological conditions.
Become an expert on molecular and cellular aspects of development and disease and create a better understanding of processes underlying cancer and developmental biology. Use techniques and applications of post-genomic research, including single cell and next generation sequencing, proteomics, metabolomics and advanced microscopy techniques.
This course will enhance your knowledge and understanding of cancer therapies and provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade, from target evaluation and engagement to clinical trials.
The programme was developed in response to the increasing demand for a course which focuses on current and emerging cancer therapies. It is the only programme in the UK which combines a focus on cancer biology with the practical, ethical and economic implications of personalised cancer therapy, along with its biology and the discovery and development of drugs.
It has been constructed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.
You'll focus on anti-cancer treatment therapies, with a particular emphasis on personalised medicine, covering the therapeutic target and the biological mechanisms of current and emerging anti-cancer therapies. You'll also explore radiotherapy as a diagnostic and as a single or combinational treatment with drugs in anti-cancer therapy.
You'll be introduced to the discovery and development of new drugs and the challenges associated with this process. You'll be able to evaluate the drug discovery pipeline including medicinal chemistry, screening, secondary assays and other drug discovery and development technologies. Through a virtual drug discovery programme, you'll have the opportunity to develop anti-cancer agents and progress these through the drug discovery cascade, from target engagement to clinical trials.
The programme will equip you with a range of skills including scientific writing, critical analysis, problem-solving, teamworking, as well as advanced data set analysis and interpretation. You'll experience a wide range of scientific topics from molecular biology, to cell biology and genetics, medicinal chemistry to formulation and radiobiology to nuclear medicine. You'll have the opportunity to conduct independent research and working as part of a multidisciplinary team you'll gain an appreciation of the contributions other disciplines make to cancer drug discovery.
The Strathclyde Institute of Pharmacy & Biomedical Sciences is recognised as one of the foremost departments of its kind in the UK. It's a leading research centre in the search for new and improved medicines. You'll benefit from the advanced facilities of a new £36 million building. The Institute is ranked no 2 in the UK in the Complete University Guide 2018 and the University of Strathclyde has recently been one of the few UK institutes to be awarded the status of 'Emerging Centre of excellence for radiobiology research' in the UK.
The course is delivered through lectures, workshops, tutorials and hands-on practical sessions.
If you successfully complete the required taught classes you may undertake a laboratory project on the subject of cancer therapies for the MSc.
Written examinations, course work with formative and summative approaches are taken in different aspects of the course. Written reports, oral presentations, scenario-based learning and moderated peer assessment are all included in the course.
Graduates will have a number of potential employment opportunities: large and small pharma companies, SMEs, within health services and providers, their home institutions and as academics in UK, EU or international Universities.
The course will enable careers in research, academia industry and the health sector and offers you a unique exposure to the entire drug discovery and development cascade while keeping patients' needs at the forefront of the learning process.